Menu
About Us
Overview
Board
Team
Corporate Directory
Our Science
Gene Silencing
Intellectual Property
Partnering
Our Programs
Areas of Research
Pipeline
Out-Licensed Programs
Presentations and Publications
For Investors
Overview
News & Events
Company Info
Financial Info
Stock Data
SEC Filings
Governance
Contact Us
Financial Results
Investors
Investors
Overview
News & Events
Overview
Press Releases
Events
Media Coverage
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Financial Info
Overview
Financial Results
Annual Reports
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Financial Info
Overview
Financial Results
Annual Reports
2023
Q3 2023
Quarter Ended Mar 31, 2023
Earnings Release
PDF
HTML
10-Q
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
Q2 2023
Quarter Ended Dec 31, 2022
Earnings Release
PDF
HTML
10-Q
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
Q1 2023
Quarter Ended Sep 30, 2022
Earnings Release
PDF
HTML
10-Q
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
2022
FY 2022
Fiscal Year Ended Jun 30, 2022
Earnings Release
PDF
HTML
10-K
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
Q3 2022
Quarter Ended Mar 31, 2022
Earnings Release
PDF
HTML
10-Q
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
Q2 2022
Quarter Ended Dec 31, 2021
Earnings Release
PDF
HTML
10-Q
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
Q1 2022
Quarter Ended Sep 30, 2021
Earnings Release
PDF
HTML
10-Q
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
2021
FY 2021
Fiscal Year Ended Jun 30, 2021
Earnings Release
PDF
HTML
10-K
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
Q3 2021
Quarter Ended Mar 31, 2021
10-Q
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
Q2 2021
Quarter Ended Dec 31, 2020
10-Q
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
Q1 2021
Quarter Ended Sep 30, 2020
10-Q
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
2020
FY 2020
Fiscal Year Ended Jun 30, 2020
Earnings Release
PDF
HTML
10-K
Filing
PDF
HTML
Email Alerts
Contacts
RSS News Feed